These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 1565633)

  • 1. Vaccinia virus recombinants expressing chimeric proteins of human immunodeficiency virus and gamma interferon are attenuated for nude mice.
    Giavedoni LD; Jones L; Gardner MB; Gibson HL; Ng CT; Barr PJ; Yilma T
    Proc Natl Acad Sci U S A; 1992 Apr; 89(8):3409-13. PubMed ID: 1565633
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improving recombinant MVA immune responses: potentiation of the immune responses to HIV-1 with MVA and DNA vectors expressing Env and the cytokines IL-12 and IFN-gamma.
    Abaitua F; Rodríguez JR; Garzón A; Rodríguez D; Esteban M
    Virus Res; 2006 Mar; 116(1-2):11-20. PubMed ID: 16214252
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of cytolytic T lymphocytes directed towards the V3 loop of the human immunodeficiency virus type 1 external glycoprotein gp120 by p55gag/V3 chimeric vaccinia viruses.
    Wagner R; Böltz T; Deml L; Modrow S; Wolf H
    J Gen Virol; 1993 Jul; 74 ( Pt 7)():1261-9. PubMed ID: 7687647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficient CD8+ T cell response to the HIV-env V3 loop epitope from multiple virus isolates by a DNA prime/vaccinia virus boost (rWR and rMVA strains) immunization regime and enhancement by the cytokine IFN-gamma.
    Gómez CE; Abaitua F; Rodríguez D; Esteban M
    Virus Res; 2004 Sep; 105(1):11-22. PubMed ID: 15325077
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IL-18 expression results in a recombinant vaccinia virus that is highly attenuated and immunogenic.
    Verardi PH; Legrand FA; Chan KS; Peng Y; Jones LA; Yilma TD
    J Interferon Cytokine Res; 2014 Mar; 34(3):169-78. PubMed ID: 24168450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polygene DNA vaccine induces a high level of protective effect against HIV-vaccinia virus challenge in mice.
    Shinoda K; Xin KQ; Jounai N; Kojima Y; Tamura Y; Okada E; Kawamoto S; Okuda K; Klinman D; Okuda K
    Vaccine; 2004 Sep; 22(27-28):3676-90. PubMed ID: 15315847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chimeric gag-V3 virus-like particles of human immunodeficiency virus induce virus-neutralizing antibodies.
    Luo L; Li Y; Cannon PM; Kim S; Kang CY
    Proc Natl Acad Sci U S A; 1992 Nov; 89(21):10527-31. PubMed ID: 1438241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Species specificity of ectromelia virus and vaccinia virus interferon-gamma binding proteins.
    Mossman K; Upton C; Buller RM; McFadden G
    Virology; 1995 Apr; 208(2):762-9. PubMed ID: 7747448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Chimeric HIV-1 gp120 Fused with Vaccinia Virus 14K (A27) Protein as an HIV Immunogen.
    Vijayan A; García-Arriaza J; Raman SC; Conesa JJ; Chichón FJ; Santiago C; Sorzano CÓ; Carrascosa JL; Esteban M
    PLoS One; 2015; 10(7):e0133595. PubMed ID: 26208356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunogenicity of recombinant Modified Vaccinia Ankara Viruses (rMVA) expressing HIV-1 Indian subtype C gag-protease and env-gp120 genes in mice.
    Kumar S; Seth P
    Viral Immunol; 2004; 17(4):574-9. PubMed ID: 15671754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunogenicity and virulence of attenuated vaccinia virus Tian Tan encoding HIV-1 muti-epitope genes, p24 and cholera toxin B subunit in mice.
    Du S; Wang Y; Liu C; Wang M; Zhu Y; Tan P; Ren D; Li X; Tian M; Yin R; Li C; Jin N
    J Virol Methods; 2015 Jul; 219():1-9. PubMed ID: 25796990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of human immunodeficiency virus type 1 and vaccinia virus infection by a dominant negative factor of the interferon regulatory factor family expressed in monocytic cells.
    Thornton AM; Buller RM; DeVico AL; Wang IM; Ozato K
    Proc Natl Acad Sci U S A; 1996 Jan; 93(1):383-7. PubMed ID: 8552643
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV-1 Subtype C Mosaic Gag Expressed by BCG and MVA Elicits Persistent Effector T Cell Responses in a Prime-Boost Regimen in Mice.
    Jongwe TI; Chapman R; Douglass N; Chetty S; Chege G; Williamson AL
    PLoS One; 2016; 11(7):e0159141. PubMed ID: 27427967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative studies of gamma-interferon receptor-like proteins of variola major and variola minor viruses.
    Seregin SV; Babkina IN; Nesterov AE; Sinyakov AN; Shchelkunov SN
    FEBS Lett; 1996 Mar; 382(1-2):79-83. PubMed ID: 8612768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Attenuation of a vaccine strain of vaccinia virus via inactivation of interferon viroceptor.
    Dénes B; Gridley DS; Fodor N; Takátsy Z; Timiryasova TM; Fodor I
    J Gene Med; 2006 Jul; 8(7):814-23. PubMed ID: 16634110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaccinia virus gene A36R encodes a M(r) 43-50 K protein on the surface of extracellular enveloped virus.
    Parkinson JE; Smith GL
    Virology; 1994 Oct; 204(1):376-90. PubMed ID: 8091668
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reintroduction of gene(s) into an attenuated deletion mutant of vaccinia virus strain IHD-W.
    Chang PY; Pogo BG
    Microb Pathog; 1993 Nov; 15(5):347-57. PubMed ID: 8015416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression and identification of immunological activities of the HIV-gp120N-human interferon gamma fusion protein.
    Feng TT; Zhao G; Yao HP; Wang QP; Wu NP
    Anat Rec (Hoboken); 2009 Mar; 292(3):381-6. PubMed ID: 19248157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of persistent infections with vaccinia virus recombinants to introduce alterations in foreign proteins: an application to HIV-1 env protein.
    Esteban M; Ramón Rodríguez J; Jimenez V; Rodríguez D
    Virus Res; 1996 Dec; 46(1-2):45-56. PubMed ID: 9029776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathogenicity and immunogenicity of recombinant Tiantan Vaccinia Virus with deleted C12L and A53R genes.
    Dai K; Liu Y; Liu M; Xu J; Huang W; Huang X; Liu L; Wan Y; Hao Y; Shao Y
    Vaccine; 2008 Sep; 26(39):5062-71. PubMed ID: 18573290
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.